Listar por autoría "bb0b3953-dbe9-459a-95bd-c5cc32ed91fa"

Mostrando ítems 1-3 de 3

    • closedAccess   Mucin 1 deficiency mediates corticosteroid insensitivity in asthma 

      MILARA, JAVIER; Morell, Anselm; de Diego, Alfredo; Artigues, Enrique; Morcillo, Esteban; Cortijo, Julio Wiley (2019-01)
      BACKGROUND: The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor asthma control and deterioration of airflow. Recent data indicate that Mucin 1 (MUC1) membrane mucin ...

    • openAccess   New GOLD classification: longitudinal data on group assignment 

      Casanova, Ciro; Marin, Jose M.; Martinez-Gonzalez, Cristina; Lucas-Ramos, Pilar de; Mir-Viladrich, Isabel; Cosio, Borja; Peces-Barba, Germán; Calle-Rubio, Miryam; Solanes-García, Ingrid; Agüero Balbin, Ramón; de Diego, Alfredo; Feu-Collado, Nuria; Alfageme Michavila, Inmaculada; Irigaray, Rosa; Balcells, Eva; Llunell Casanovas, Antònia; Bautista i García, Joan Damià; Marín Royo, Margarita; Soler-Cataluña, Juan J.; Lopez-Campos, Jose Luis; Soriano, Joan B.; Torres, Juan P. de; COPD History Assessment In SpaiN (CHAIN) cohort BioMed Central (2014)
      Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD). Objective: To determine the COPD ...

    • openAccess   Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients 

      MILARA, JAVIER; Cervera, Angela; de Diego, Alfredo; Sanz, Celia; Juan, Gustavo; Gavaldà, Amadeu; Miralpeix, Montserrat; Morcillo, Esteban; Cortijo, Julio BioMed Central (2016)
      Background: Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented combination therapy for chronic obstructive pulmonary disease (COPD) based on its additive anti-inflammatory properties. By ...